Meghan A Baker
Meghan A Baker, MD, ScD
1
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA
2
Infection Control Department, Brigham and Women’s Hospital, Boston, MA, USA
3
Infection Control Department, Dana Farber Cancer Institute, Boston, MA, USA
1,2,3,
Chanu Rhee
Chanu Rhee, MD, MPH
1
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA
2
Infection Control Department, Brigham and Women’s Hospital, Boston, MA, USA
1,2,
Robert Tucker
Robert Tucker, MPH
2
Infection Control Department, Brigham and Women’s Hospital, Boston, MA, USA
2,
Amy Badwaik
Amy Badwaik, CIC
2
Infection Control Department, Brigham and Women’s Hospital, Boston, MA, USA
2,
Cassie Coughlin
Cassie Coughlin, RN, BSN
3
Infection Control Department, Dana Farber Cancer Institute, Boston, MA, USA
3,
Meghan A Holtzman
Meghan A Holtzman, CIC
2
Infection Control Department, Brigham and Women’s Hospital, Boston, MA, USA
2,
Candace Hsieh
Candace Hsieh, RN, CIC
3
Infection Control Department, Dana Farber Cancer Institute, Boston, MA, USA
3,
Angela Maguire
Angela Maguire, RN
2
Infection Control Department, Brigham and Women’s Hospital, Boston, MA, USA
2,
Elizabeth Mermel Blaeser
Elizabeth Mermel Blaeser, CIC
2
Infection Control Department, Brigham and Women’s Hospital, Boston, MA, USA
2,
Saranya Seetharaman
Saranya Seetharaman, MBBS, MPH
2
Infection Control Department, Brigham and Women’s Hospital, Boston, MA, USA
2,
Ofelia Solem
Ofelia Solem, RN, CIC
2
Infection Control Department, Brigham and Women’s Hospital, Boston, MA, USA
2,
Vineeta Vaidya
Vineeta Vaidya, CIC
2
Infection Control Department, Brigham and Women’s Hospital, Boston, MA, USA
2,
Michael Klompas
Michael Klompas, MD, MPH
1
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA
2
Infection Control Department, Brigham and Women’s Hospital, Boston, MA, USA
1,2,✉
1
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA
2
Infection Control Department, Brigham and Women’s Hospital, Boston, MA, USA
3
Infection Control Department, Dana Farber Cancer Institute, Boston, MA, USA
✉Corresponding author: Michael Klompas MD, MPH Department of Population Medicine 401 Park Drive, Suite 401 East Boston, MA, 02215 USA Email: klompas@bwh.harvard.edu
© The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
